4.7 Article

Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice

Related references

Note: Only part of the references are listed.
Article Oncology

Bmi1 knockdown inhibits hepatocarcinogenesis

Zhi-Ping Ruan et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2013)

Article Medicine, General & Internal

Hepatocellular carcinoma

Alejandro Forner et al.

LANCET (2012)

Article Multidisciplinary Sciences

Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer

Enfeng Wang et al.

PLOS ONE (2011)

Review Biochemistry & Molecular Biology

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

S. Whittaker et al.

ONCOGENE (2010)

Article Oncology

Expression of Bmi-1 is a prognostic marker in bladder cancer

Zi-Ke Qin et al.

BMC CANCER (2009)

Article Cell Biology

Bmi-1 regulates the Ink4a/Arf locus to control pancreatic β-cell proliferation

Sangeeta Dhawan et al.

GENES & DEVELOPMENT (2009)

Article Biochemistry & Molecular Biology

BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases

M. J. Hoenerhoff et al.

ONCOGENE (2009)

Article Multidisciplinary Sciences

Polycomb Group Protein Bmi1 Is Required for Growth of RAF Driven Non-Small-Cell Lung Cancer

Matthias Becker et al.

PLOS ONE (2009)

Article Gastroenterology & Hepatology

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics

Mohamed IF Shariff et al.

Expert Review of Gastroenterology & Hepatology (2009)

Article Biochemistry & Molecular Biology

Bmi1 promotes prostate tumorigenesis via inhibiting p16INK4A and p14ARF expression

Catherine Fan et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)

Article Oncology

BMI-1 promotes Ewing sarcoma tumorigenicity independent of CDKN2A repression

Dorothea Douglas et al.

CANCER RESEARCH (2008)

Editorial Material Medicine, General & Internal

Sorafenib in liver cancer - Just the beginning

Lewis R. Roberts

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Multidisciplinary Sciences

Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion

Jennifer Shepard Dovey et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Oncology

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

Alexandra M. Pietersen et al.

BREAST CANCER RESEARCH (2008)

Article Multidisciplinary Sciences

Distinct pathways of genomic progression to benign and malignant tumors of the liver

Aaron D. Tward et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Gastroenterology & Hepatology

Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation

Tetsuhiro Chiba et al.

GASTROENTEROLOGY (2007)

Article Biochemistry & Molecular Biology

Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis

Dmitri Wiederschain et al.

MOLECULAR AND CELLULAR BIOLOGY (2007)

Review Oncology

Polycomb silencers control cell fate, development and cancer

Anke Sparmann et al.

NATURE REVIEWS CANCER (2006)

Article Biochemical Research Methods

BrdU assay for neurogenesis in rodents

J. Martin Wojtowicz et al.

NATURE PROTOCOLS (2006)

Article Medicine, Research & Experimental

Bmi1, stem cells, and senescence regulation

IK Park et al.

JOURNAL OF CLINICAL INVESTIGATION (2004)

Article Multidisciplinary Sciences

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

J Lessard et al.

NATURE (2003)

Article Genetics & Heredity

Molecular pathogenesis of human hepatocellular carcinoma

SS Thorgeirsson et al.

NATURE GENETICS (2002)